What is he best known for?
The fields of study he is best known for:
- Cancer
- Internal medicine
- Gene
Michiie Sakamoto mostly deals with Hepatocellular carcinoma, Pathology, Cancer research, Internal medicine and Carcinoma.
His Hepatocellular carcinoma research is multidisciplinary, relying on both Tumor size, Cancer, Cirrhosis, Hepatitis and Radiology.
His research in Pathology is mostly concerned with Immunohistochemistry.
His biological study spans a wide range of topics, including Cell culture, Gene expression, DNA methylation and Loss of heterozygosity.
Michiie Sakamoto combines subjects such as Gastroenterology and Oncology with his study of Internal medicine.
The Carcinoma study combines topics in areas such as Lipiodol, Endocrinology, Early Hepatocellular Carcinoma and Histopathology.
His most cited work include:
- Adoptive immunotherapy to lower postsurgical recurrence rates of hepatocellular carcinoma: a randomised trial. (698 citations)
- Management of Hepatocellular Carcinoma in Japan: Consensus-Based Clinical Practice Guidelines Proposed by the Japan Society of Hepatology (JSH) 2010 Updated Version (586 citations)
- Pathologic Diagnosis of Early Hepatocellular Carcinoma: A Report of the International Consensus Group for Hepatocellular Neoplasia (568 citations)
What are the main themes of his work throughout his whole career to date?
The scientist’s investigation covers issues in Pathology, Hepatocellular carcinoma, Internal medicine, Cancer research and Gastroenterology.
Michiie Sakamoto studies Pathology, focusing on Immunohistochemistry in particular.
His work in Hepatocellular carcinoma tackles topics such as Carcinoma which are related to areas like Biopsy.
His Internal medicine study integrates concerns from other disciplines, such as Hepatectomy, Oncology and Endocrinology.
As part of one scientific family, Michiie Sakamoto deals mainly with the area of Cancer research, narrowing it down to issues related to the DNA methylation, and often Methylation.
His Gastroenterology research integrates issues from Fibrosis and Surgery.
He most often published in these fields:
- Pathology (46.87%)
- Hepatocellular carcinoma (38.75%)
- Internal medicine (31.25%)
What were the highlights of his more recent work (between 2014-2021)?
- Hepatocellular carcinoma (38.75%)
- Internal medicine (31.25%)
- Pathology (46.87%)
In recent papers he was focusing on the following fields of study:
Michiie Sakamoto mainly focuses on Hepatocellular carcinoma, Internal medicine, Pathology, Gastroenterology and Cancer research.
Michiie Sakamoto interconnects Resection, Carcinoma and Propensity score matching in the investigation of issues within Hepatocellular carcinoma.
His study looks at the intersection of Internal medicine and topics like Oncology with Disease.
His Pathology study combines topics in areas such as Cancer cell and Stem cell.
His Cancer research study also includes fields such as
- Cell growth, which have a strong connection to Cell culture,
- Cell which connect with Downregulation and upregulation.
His studies deal with areas such as Cancer and Staining as well as Immunohistochemistry.
Between 2014 and 2021, his most popular works were:
- Survival benefit of liver resection for hepatocellular carcinoma associated with portal vein invasion (158 citations)
- cHCC-CCA: Consensus terminology for primary liver carcinomas with both hepatocytic and cholangiocytic differentation. (109 citations)
- Association between Wisteria floribunda agglutinin-positive Mac-2 binding protein and the fibrosis stage of non-alcoholic fatty liver disease (107 citations)
In his most recent research, the most cited papers focused on:
- Cancer
- Internal medicine
- Gene
Michiie Sakamoto spends much of his time researching Internal medicine, Hepatocellular carcinoma, Gastroenterology, Carcinoma and Pathology.
As a part of the same scientific family, he mostly works in the field of Internal medicine, focusing on Oncology and, on occasion, Intrahepatic Cholangiocarcinoma, Cohort study and Local Ablation Therapy.
His research in Hepatocellular carcinoma intersects with topics in Retrospective cohort study, Radiofrequency ablation, Propensity score matching, Hepatectomy and Survival analysis.
His work deals with themes such as Stage, Surgery, Liver cancer, Fibrosis and Receiver operating characteristic, which intersect with Gastroenterology.
His work focuses on many connections between Pathology and other disciplines, such as Cancer cell, that overlap with his field of interest in Adenocarcinoma, Immunohistochemistry, Epithelial–mesenchymal transition and Gene knockdown.
His research investigates the connection between Tumor microenvironment and topics such as Carcinogenesis that intersect with issues in Cancer research.
This overview was generated by a machine learning system which analysed the scientist’s
body of work. If you have any feedback, you can
contact us
here.
